文献速递临床试验与 GCP

CHALLENGE试验:虚拟现实辅助暴露疗法对比支持性咨询对精神病患者持续性幻听的影响——一项随机临床试验的研究方案

The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial.
PubMed 文献 · Trials · 2022-09-13

该试验为随机、评估者设盲的平行组优效性临床试验,计划纳入266例精神病患者,随机接受7次虚拟现实治疗或7次支持性咨询,均在入组后12周内完成。主要结局为12周治疗结束时PSYRATS-AH总分,评估虚拟现实疗法对持续性幻听严重程度、频率及痛苦感的影响。

要点

  • 试验比较虚拟现实辅助暴露疗法与支持性咨询对持续性幻听的疗效。
  • 主要结局为12周时PSYRATS-AH总分,次要结局包括幻听频率、痛苦感及社会功能。
  • 共计划纳入266例患者,随机分配至两组,每组各接受7次治疗。

核心结论

  • 该试验旨在检验针对持续性幻听的虚拟现实疗法能否减轻幻听的严重程度、频率和痛苦感,并减少临床并改善日常功能。

研究设计与样本

  • 随机、评估者设盲的平行组优效性临床试验,计划纳入266例精神病患者,随机分配至虚拟现实治疗组或支持性咨询组。
  • 两组均在入组后12周内接受7次治疗,在基线、12周和24周进行评估,独立评估者设盲。

主要发现

  • 主要结局为12周治疗结束时以精神病症状评定量表幻听分量表(PSYRATS-AH)总分衡量的幻听水平。
  • 次要结局包括幻听频率、幻听所致痛苦、感知声音力量、患者对声音的接受度、患者以自信方式回应声音的能力及社会和日常功能。

局限性

  • 原文指出该沉浸式虚拟现实疗法对幻听的疗效虽已有 promising 证据,但需在大型、方法学严谨的试验中确立证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many patients suffering from schizophrenia spectrum disorders continue having distressing auditory hallucinations in spite of treatment with antipsychotic medication. The aim of this trial is to examine the effect of a targeted virtual reality therapy for persistent auditory hallucinations in individuals with psychosis. The trial explores whether this type of therapy can decrease the severity, frequency and distress of auditory hallucinations and, additionally, whether it can reduce clinical symptoms and enhance daily functioning in individuals with psychosis. METHODS: The study is a randomised, assessor-blinded parallel-group superiority clinical trial, allocating a total of 266 patients to either the experimental intervention or supportive counselling. The participants will be randomised to either (1) seven sessions of virtual reality therapy or (2) seven sessions of supportive counselling to be delivered within the first 12 weeks after inclusion in the study. All participants will be assessed at baseline and 12 and 24 weeks post-baseline. Independent assessors blinded to the treatment allocation will evaluate the outcome. The primary outcome is the level of auditory hallucinations measured with the Psychotic Symptoms Rating Scales (PSYRATS-AH) total score at the cessation of treatment at 12 weeks. Secondary outcomes are frequency of auditory hallucinations, the distress caused by auditory hallucinations, perceived voice power, patient acceptance of voices, patients' ability to respond to voices in an assertive way and social and daily function. DISCUSSION: Promising evidence of the efficacy of this immersive virtual reality-based therapy for auditory hallucinations exist, but evidence needs to be established in a large, methodological rigorous trial. If the therapy proves to be beneficial in reducing the severity of refractory auditory hallucinations, a large group of patients with schizophrenia and related disorders could be the target group of this short-term psychotherapeutic intervention.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Smith LC, Mariegaard L, Vernal DL, et al. The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial. Trials. 2022. PMID: 36100943. doi:10.1186/s13063-022-06683-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。